拱东医疗收盘上涨1.13%，滚动市盈率24.25倍，总市值39.35亿元

Core Viewpoint - The company, Zhejiang Gongdong Medical Instrument Co., Ltd., is experiencing growth in revenue and net profit, with a significant increase in both metrics year-on-year, indicating a strong performance in the medical device industry [1][2]. Company Summary - Gongdong Medical's stock closed at 24.97 yuan, up 1.13%, with a rolling PE ratio of 24.25 times and a total market capitalization of 3.935 billion yuan [1]. - The company specializes in the research, production, and sales of disposable medical consumables, including vacuum blood collection systems, laboratory testing consumables, bodily fluid collection consumables, medical care consumables, and pharmaceutical packaging materials [1]. - As of the third quarter of 2024, 67 institutions hold shares in Gongdong Medical, with a total of 8.8357 million shares valued at 248 million yuan [1]. Financial Performance - For the third quarter of 2024, Gongdong Medical reported an operating income of 836 million yuan, a year-on-year increase of 17.31%, and a net profit of 141 million yuan, reflecting a year-on-year growth of 60.22% [2]. - The company's gross profit margin stands at 33.35% [2]. Industry Context - The average PE ratio for the medical device industry is 46.15 times, with a median of 29.13 times, positioning Gongdong Medical at the 59th rank within the industry [1][2]. - The industry shows a wide range of PE ratios, with some companies exhibiting extremely high or negative values, indicating varying levels of performance and market perception [2].